Global Non-opioid Analgesic Patch Market Growth 2022-2028

Publisher Name :
Date: 13-Jan-2022
No. of pages: 106

As the global economy mends, the 2021 growth of Non-opioid Analgesic Patch will have significant change from previous year. According to our (LP Information) latest study, the global Non-opioid Analgesic Patch market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Non-opioid Analgesic Patch market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Non-opioid Analgesic Patch market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-opioid Analgesic Patch market, reaching US$ million by the year 2028. As for the Europe Non-opioid Analgesic Patch landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Non-opioid Analgesic Patch players cover GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., and Mylan N.V., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Analgesic Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

- Lidocaine Patches

- Diclofenac Patches

- Methyl Salicylate Patches

- Capsaicin Patches

- Ketoprofen Patches

- Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

- Hospital Pharmacies

- Online Pharmacies

- Independent Pharmacies & Drug Stores

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

- GlaxoSmithKline Plc

- Pfizer, Inc.

- Teikoku Seiyaku Co., Ltd.

- Mylan N.V.

- Hisamitsu Pharmaceutical Co.,Inc

- Acorda Therapeutics, Inc

- Endo International plc

- Allergan

- Teh Seng Pharmaceutical Mfg

- IBSA Institut Biochimque SA

Global Non-opioid Analgesic Patch Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-opioid Analgesic Patch Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non-opioid Analgesic Patch by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non-opioid Analgesic Patch by Country/Region, 2017, 2022 & 2028
2.2 Non-opioid Analgesic Patch Segment by Type
2.2.1 Lidocaine Patches
2.2.2 Diclofenac Patches
2.2.3 Methyl Salicylate Patches
2.2.4 Capsaicin Patches
2.2.5 Ketoprofen Patches
2.2.6 Others
2.3 Non-opioid Analgesic Patch Sales by Type
2.3.1 Global Non-opioid Analgesic Patch Sales Market Share by Type (2017-2022)
2.3.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non-opioid Analgesic Patch Sale Price by Type (2017-2022)
2.4 Non-opioid Analgesic Patch Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Independent Pharmacies & Drug Stores
2.5 Non-opioid Analgesic Patch Sales by Application
2.5.1 Global Non-opioid Analgesic Patch Sale Market Share by Application (2017-2022)
2.5.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non-opioid Analgesic Patch Sale Price by Application (2017-2022)
3 Global Non-opioid Analgesic Patch by Company
3.1 Global Non-opioid Analgesic Patch Breakdown Data by Company
3.1.1 Global Non-opioid Analgesic Patch Annual Sales by Company (2020-2022)
3.1.2 Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2022)
3.2 Global Non-opioid Analgesic Patch Annual Revenue by Company (2020-2022)
3.2.1 Global Non-opioid Analgesic Patch Revenue by Company (2020-2022)
3.2.2 Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2022)
3.3 Global Non-opioid Analgesic Patch Sale Price by Company
3.4 Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Analgesic Patch Product Location Distribution
3.4.2 Players Non-opioid Analgesic Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-opioid Analgesic Patch by Geographic Region
4.1 World Historic Non-opioid Analgesic Patch Market Size by Geographic Region (2017-2022)
4.1.1 Global Non-opioid Analgesic Patch Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non-opioid Analgesic Patch Annual Revenue by Geographic Region
4.2 World Historic Non-opioid Analgesic Patch Market Size by Country/Region (2017-2022)
4.2.1 Global Non-opioid Analgesic Patch Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non-opioid Analgesic Patch Annual Revenue by Country/Region
4.3 Americas Non-opioid Analgesic Patch Sales Growth
4.4 APAC Non-opioid Analgesic Patch Sales Growth
4.5 Europe Non-opioid Analgesic Patch Sales Growth
4.6 Middle East & Africa Non-opioid Analgesic Patch Sales Growth
5 Americas
5.1 Americas Non-opioid Analgesic Patch Sales by Country
5.1.1 Americas Non-opioid Analgesic Patch Sales by Country (2017-2022)
5.1.2 Americas Non-opioid Analgesic Patch Revenue by Country (2017-2022)
5.2 Americas Non-opioid Analgesic Patch Sales by Type
5.3 Americas Non-opioid Analgesic Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Analgesic Patch Sales by Region
6.1.1 APAC Non-opioid Analgesic Patch Sales by Region (2017-2022)
6.1.2 APAC Non-opioid Analgesic Patch Revenue by Region (2017-2022)
6.2 APAC Non-opioid Analgesic Patch Sales by Type
6.3 APAC Non-opioid Analgesic Patch Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-opioid Analgesic Patch by Country
7.1.1 Europe Non-opioid Analgesic Patch Sales by Country (2017-2022)
7.1.2 Europe Non-opioid Analgesic Patch Revenue by Country (2017-2022)
7.2 Europe Non-opioid Analgesic Patch Sales by Type
7.3 Europe Non-opioid Analgesic Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-opioid Analgesic Patch by Country
8.1.1 Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2017-2022)
8.2 Middle East & Africa Non-opioid Analgesic Patch Sales by Type
8.3 Middle East & Africa Non-opioid Analgesic Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch
10.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch
10.4 Industry Chain Structure of Non-opioid Analgesic Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Analgesic Patch Distributors
11.3 Non-opioid Analgesic Patch Customer
12 World Forecast Review for Non-opioid Analgesic Patch by Geographic Region
12.1 Global Non-opioid Analgesic Patch Market Size Forecast by Region
12.1.1 Global Non-opioid Analgesic Patch Forecast by Region (2023-2028)
12.1.2 Global Non-opioid Analgesic Patch Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-opioid Analgesic Patch Forecast by Type
12.7 Global Non-opioid Analgesic Patch Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline Plc
13.1.1 GlaxoSmithKline Plc Company Information
13.1.2 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Offered
13.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Plc Main Business Overview
13.1.5 GlaxoSmithKline Plc Latest Developments
13.2 Pfizer, Inc.
13.2.1 Pfizer, Inc. Company Information
13.2.2 Pfizer, Inc. Non-opioid Analgesic Patch Product Offered
13.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer, Inc. Main Business Overview
13.2.5 Pfizer, Inc. Latest Developments
13.3 Teikoku Seiyaku Co., Ltd.
13.3.1 Teikoku Seiyaku Co., Ltd. Company Information
13.3.2 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Offered
13.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teikoku Seiyaku Co., Ltd. Main Business Overview
13.3.5 Teikoku Seiyaku Co., Ltd. Latest Developments
13.4 Mylan N.V.
13.4.1 Mylan N.V. Company Information
13.4.2 Mylan N.V. Non-opioid Analgesic Patch Product Offered
13.4.3 Mylan N.V. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mylan N.V. Main Business Overview
13.4.5 Mylan N.V. Latest Developments
13.5 Hisamitsu Pharmaceutical Co.,Inc
13.5.1 Hisamitsu Pharmaceutical Co.,Inc Company Information
13.5.2 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Offered
13.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hisamitsu Pharmaceutical Co.,Inc Main Business Overview
13.5.5 Hisamitsu Pharmaceutical Co.,Inc Latest Developments
13.6 Acorda Therapeutics, Inc
13.6.1 Acorda Therapeutics, Inc Company Information
13.6.2 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Offered
13.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Acorda Therapeutics, Inc Main Business Overview
13.6.5 Acorda Therapeutics, Inc Latest Developments
13.7 Endo International plc
13.7.1 Endo International plc Company Information
13.7.2 Endo International plc Non-opioid Analgesic Patch Product Offered
13.7.3 Endo International plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Endo International plc Main Business Overview
13.7.5 Endo International plc Latest Developments
13.8 Allergan
13.8.1 Allergan Company Information
13.8.2 Allergan Non-opioid Analgesic Patch Product Offered
13.8.3 Allergan Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Allergan Main Business Overview
13.8.5 Allergan Latest Developments
13.9 Teh Seng Pharmaceutical Mfg
13.9.1 Teh Seng Pharmaceutical Mfg Company Information
13.9.2 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Offered
13.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teh Seng Pharmaceutical Mfg Main Business Overview
13.9.5 Teh Seng Pharmaceutical Mfg Latest Developments
13.10 IBSA Institut Biochimque SA
13.10.1 IBSA Institut Biochimque SA Company Information
13.10.2 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Offered
13.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 IBSA Institut Biochimque SA Main Business Overview
13.10.5 IBSA Institut Biochimque SA Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Non-opioid Analgesic Patch Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non-opioid Analgesic Patch Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Lidocaine Patches
Table 4. Major Players of Diclofenac Patches
Table 5. Major Players of Methyl Salicylate Patches
Table 6. Major Players of Capsaicin Patches
Table 7. Major Players of Ketoprofen Patches
Table 8. Major Players of Others
Table 9. Global Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 10. Global Non-opioid Analgesic Patch Sales Market Share by Type (2017-2022)
Table 11. Global Non-opioid Analgesic Patch Revenue by Type (2017-2022) & ($ million)
Table 12. Global Non-opioid Analgesic Patch Revenue Market Share by Type (2017-2022)
Table 13. Global Non-opioid Analgesic Patch Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 15. Global Non-opioid Analgesic Patch Sales Market Share by Application (2017-2022)
Table 16. Global Non-opioid Analgesic Patch Revenue by Application (2017-2022)
Table 17. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2017-2022)
Table 18. Global Non-opioid Analgesic Patch Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global Non-opioid Analgesic Patch Sales by Company (2020-2022) & (K Units)
Table 20. Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2022)
Table 21. Global Non-opioid Analgesic Patch Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2022)
Table 23. Global Non-opioid Analgesic Patch Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Analgesic Patch Products Offered
Table 26. Non-opioid Analgesic Patch Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Non-opioid Analgesic Patch Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Non-opioid Analgesic Patch Sales Market Share Geographic Region (2017-2022)
Table 31. Global Non-opioid Analgesic Patch Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Non-opioid Analgesic Patch Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Non-opioid Analgesic Patch Sales Market Share by Country/Region (2017-2022)
Table 35. Global Non-opioid Analgesic Patch Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Non-opioid Analgesic Patch Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Non-opioid Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 38. Americas Non-opioid Analgesic Patch Sales Market Share by Country (2017-2022)
Table 39. Americas Non-opioid Analgesic Patch Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Non-opioid Analgesic Patch Revenue Market Share by Country (2017-2022)
Table 41. Americas Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 42. Americas Non-opioid Analgesic Patch Sales Market Share by Type (2017-2022)
Table 43. Americas Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 44. Americas Non-opioid Analgesic Patch Sales Market Share by Application (2017-2022)
Table 45. APAC Non-opioid Analgesic Patch Sales by Region (2017-2022) & (K Units)
Table 46. APAC Non-opioid Analgesic Patch Sales Market Share by Region (2017-2022)
Table 47. APAC Non-opioid Analgesic Patch Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Non-opioid Analgesic Patch Revenue Market Share by Region (2017-2022)
Table 49. APAC Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 50. APAC Non-opioid Analgesic Patch Sales Market Share by Type (2017-2022)
Table 51. APAC Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 52. APAC Non-opioid Analgesic Patch Sales Market Share by Application (2017-2022)
Table 53. Europe Non-opioid Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 54. Europe Non-opioid Analgesic Patch Sales Market Share by Country (2017-2022)
Table 55. Europe Non-opioid Analgesic Patch Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Non-opioid Analgesic Patch Revenue Market Share by Country (2017-2022)
Table 57. Europe Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 58. Europe Non-opioid Analgesic Patch Sales Market Share by Type (2017-2022)
Table 59. Europe Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 60. Europe Non-opioid Analgesic Patch Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Non-opioid Analgesic Patch Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Non-opioid Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Non-opioid Analgesic Patch Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Non-opioid Analgesic Patch
Table 70. Key Market Challenges & Risks of Non-opioid Analgesic Patch
Table 71. Key Industry Trends of Non-opioid Analgesic Patch
Table 72. Non-opioid Analgesic Patch Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Non-opioid Analgesic Patch Distributors List
Table 75. Non-opioid Analgesic Patch Customer List
Table 76. Global Non-opioid Analgesic Patch Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Non-opioid Analgesic Patch Sales Market Forecast by Region
Table 78. Global Non-opioid Analgesic Patch Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Non-opioid Analgesic Patch Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Non-opioid Analgesic Patch Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Non-opioid Analgesic Patch Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Non-opioid Analgesic Patch Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Non-opioid Analgesic Patch Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Non-opioid Analgesic Patch Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Non-opioid Analgesic Patch Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Non-opioid Analgesic Patch Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Non-opioid Analgesic Patch Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Non-opioid Analgesic Patch Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Non-opioid Analgesic Patch Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Non-opioid Analgesic Patch Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Application (2023-2028)
Table 96. GlaxoSmithKline Plc Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 97. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Offered
Table 98. GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. GlaxoSmithKline Plc Main Business
Table 100. GlaxoSmithKline Plc Latest Developments
Table 101. Pfizer, Inc. Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer, Inc. Non-opioid Analgesic Patch Product Offered
Table 103. Pfizer, Inc. Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. Pfizer, Inc. Main Business
Table 105. Pfizer, Inc. Latest Developments
Table 106. Teikoku Seiyaku Co., Ltd. Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 107. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Offered
Table 108. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. Teikoku Seiyaku Co., Ltd. Main Business
Table 110. Teikoku Seiyaku Co., Ltd. Latest Developments
Table 111. Mylan N.V. Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 112. Mylan N.V. Non-opioid Analgesic Patch Product Offered
Table 113. Mylan N.V. Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. Mylan N.V. Main Business
Table 115. Mylan N.V. Latest Developments
Table 116. Hisamitsu Pharmaceutical Co.,Inc Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 117. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Offered
Table 118. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. Hisamitsu Pharmaceutical Co.,Inc Main Business
Table 120. Hisamitsu Pharmaceutical Co.,Inc Latest Developments
Table 121. Acorda Therapeutics, Inc Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 122. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Offered
Table 123. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 124. Acorda Therapeutics, Inc Main Business
Table 125. Acorda Therapeutics, Inc Latest Developments
Table 126. Endo International plc Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 127. Endo International plc Non-opioid Analgesic Patch Product Offered
Table 128. Endo International plc Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 129. Endo International plc Main Business
Table 130. Endo International plc Latest Developments
Table 131. Allergan Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 132. Allergan Non-opioid Analgesic Patch Product Offered
Table 133. Allergan Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 134. Allergan Main Business
Table 135. Allergan Latest Developments
Table 136. Teh Seng Pharmaceutical Mfg Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 137. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Offered
Table 138. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 139. Teh Seng Pharmaceutical Mfg Main Business
Table 140. Teh Seng Pharmaceutical Mfg Latest Developments
Table 141. IBSA Institut Biochimque SA Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 142. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Offered
Table 143. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 144. IBSA Institut Biochimque SA Main Business
Table 145. IBSA Institut Biochimque SA Latest Developments
List of Figures
Figure 1. Picture of Non-opioid Analgesic Patch
Figure 2. Non-opioid Analgesic Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Analgesic Patch Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Non-opioid Analgesic Patch Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non-opioid Analgesic Patch Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Lidocaine Patches
Figure 10. Product Picture of Diclofenac Patches
Figure 11. Product Picture of Methyl Salicylate Patches
Figure 12. Product Picture of Capsaicin Patches
Figure 13. Product Picture of Ketoprofen Patches
Figure 14. Product Picture of Others
Figure 15. Global Non-opioid Analgesic Patch Sales Market Share by Type in 2021
Figure 16. Global Non-opioid Analgesic Patch Revenue Market Share by Type (2017-2022)
Figure 17. Non-opioid Analgesic Patch Consumed in Hospital Pharmacies
Figure 18. Global Non-opioid Analgesic Patch Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 19. Non-opioid Analgesic Patch Consumed in Online Pharmacies
Figure 20. Global Non-opioid Analgesic Patch Market: Online Pharmacies (2017-2022) & (K Units)
Figure 21. Non-opioid Analgesic Patch Consumed in Independent Pharmacies & Drug Stores
Figure 22. Global Non-opioid Analgesic Patch Market: Independent Pharmacies & Drug Stores (2017-2022) & (K Units)
Figure 23. Global Non-opioid Analgesic Patch Sales Market Share by Application (2017-2022)
Figure 24. Global Non-opioid Analgesic Patch Revenue Market Share by Application in 2021
Figure 25. Non-opioid Analgesic Patch Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Non-opioid Analgesic Patch Revenue Market Share by Company in 2021
Figure 27. Global Non-opioid Analgesic Patch Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region in 2021
Figure 29. Global Non-opioid Analgesic Patch Sales Market Share by Region (2017-2022)
Figure 30. Global Non-opioid Analgesic Patch Revenue Market Share by Country/Region in 2021
Figure 31. Americas Non-opioid Analgesic Patch Sales 2017-2022 (K Units)
Figure 32. Americas Non-opioid Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 33. APAC Non-opioid Analgesic Patch Sales 2017-2022 (K Units)
Figure 34. APAC Non-opioid Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 35. Europe Non-opioid Analgesic Patch Sales 2017-2022 (K Units)
Figure 36. Europe Non-opioid Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Non-opioid Analgesic Patch Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Non-opioid Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 39. Americas Non-opioid Analgesic Patch Sales Market Share by Country in 2021
Figure 40. Americas Non-opioid Analgesic Patch Revenue Market Share by Country in 2021
Figure 41. United States Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Non-opioid Analgesic Patch Sales Market Share by Region in 2021
Figure 46. APAC Non-opioid Analgesic Patch Revenue Market Share by Regions in 2021
Figure 47. China Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Non-opioid Analgesic Patch Sales Market Share by Country in 2021
Figure 54. Europe Non-opioid Analgesic Patch Revenue Market Share by Country in 2021
Figure 55. Germany Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Non-opioid Analgesic Patch Revenue Market Share by Country in 2021
Figure 62. Egypt Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Non-opioid Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch in 2021
Figure 68. Manufacturing Process Analysis of Non-opioid Analgesic Patch
Figure 69. Industry Chain Structure of Non-opioid Analgesic Patch
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs